LeapFrog Investments

About LeapFrog Investments

LeapFrog Investments is an impact-focused private equity firm founded in 2007 by Andrew Kuper and publicly launched in 2008. The firm operates across more than 30 countries and has a strong UK presence as a global emerging-markets investor. As of 2025 it had attracted over USD 2.8 billion from global investors across its fund series, which includes the Financial Inclusion funds, Emerging Consumer funds and Fund III, with Flagship Fund IV closing in February 2024 at USD 1.02 billion, described as the largest social-impact private equity fund raised that year. It is structured as a closed-end fund manager. The firm reports that its portfolio companies reach over 600 million consumers, primarily across Africa and Asia.

Investment thesis

LeapFrog pursues a profit-with-purpose growth-equity strategy, backing high-growth companies in three sectors, financial services, healthcare and climate solutions, that serve underserved, low-income and emerging consumers. Geography is concentrated on emerging markets in Africa and Asia. The firm takes significant minority and control growth-stage stakes and partners with management teams to scale businesses for simultaneous gains in growth, profitability and measurable social impact. Its limited partner base is institutional and development-finance-oriented. Value creation runs through dedicated operating platforms including a Talent Accelerator, a customer-experience launchpad and impact labs that help portfolio companies professionalise, expand distribution and deepen consumer reach, with portfolio companies historically growing at over 22 percent annually.

Recent activity

Recent investments include Sun King in climate solutions and solar energy, Moniepoint in financial services and fintech, Redcliffe Labs in healthcare diagnostics, and Shubham Housing in financial services and housing finance. Recent exits include Fincare in financial services (2024) and Goodlife Pharmacy in healthcare (2025, partial exit). The firm reports six portfolio exits overall. The platform continues to deploy growth equity across financial services, healthcare and climate solutions in African and Asian emerging markets. Detailed buyer names and multiple data available on Pro at €49/month.